HNN3.0

Project cooperationUpdated on 19 January 2026

NAM: organoids and OoC for drug discovery, and precision medicine applications

full professor at Department of Pharmaceutical Sciences, University of Latvia

Riga, Latvia

About

We develop human-relevant New Approach Methodologies (NAMs) based on patient-derived 3D cultures and organ-on-chip (OoC) platforms. Our expertise includes tumour and matched normal organoids in pancreatic cancer and pancreatitis models, tumour–stroma co-cultures, and drug response profiling.

We have extensive experience in pancreatic cancer, supported by a well-characterised organoid library generated from more than 25 patient surgical resection samples.

We seek to contribute to Horizon Europe consortia by providing validated, scalable, and human-relevant NAMs for translational research, drug discovery, and precision medicine applications.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities

  • Project cooperation

    Patient-Derived Zebrafish Larvae Xenografts for Drug Efficacy and Stroma-Interaction Studies

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Vadims Parfejevs

    Lead researcher at Department of Pharmaceutical Sciences, University of Latvia

    Riga, Latvia

  • Project cooperation

    Organ on chips, organoids and other NAMs for biomedical research

    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Joude Cachoux

    Business Development Manager, PharmD, MPH at LEITAT

    Barcelona, Spain

  • Project cooperation

    Expert in Hydrogel Fabrication for Oncology

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Judith Guasch

    Group Leader - Principal Investigator at ICMAB-CSIC

    Barcelona, Spain